Cytomx Therapeutics Inc (CTMX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CTMX Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Cytomx Therapeutics Inc manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent28.83
Available-for-sale Securities, Debt Securities, Current MA317.88
Cash & Short-term Investments345.00
Accounts receivable0.65
Other Current Assets0.00
Prepaid Expense And Other Assets Current5.74
Total Current Assets353.10
Equipment/Property/Plant Net1.09
Goodwill net0.95
Intangible Assets0.40
Other Assets, Noncurrent3.82
Restricted Cash Noncurrent1.53
Total Assets359.36
Liabilities
Accounts Payable, Current AC1.37
Accrued Liabilities, Current AC11.92
Other Liabilities, Current20.73
Total Current Liabilities34.02
Total Long-term Debt0.00
Other liabilities, Noncurrent5.39
Contract With Customer Liability Current17.88
Contract With Customer Liability Noncurrent0.98
Total Liabilities39.41
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock1,050.04
Retained Earnings / Accumulated Deficit-730.20
Other Equity0.10
Common Stockholder's Equity319.94
Total Stockholder's Equity319.94
Liabilities & Stockholder's Equity359.36
4 historic quarters locked

Sign in to unlock the full Cytomx Therapeutics Inc balance sheet history.

About Cytomx Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-337950

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.